Search
Descriptor English: Veratrine
Descriptor Spanish: Veratrina
Descriptor veratrina
Entry term(s) (3-beta(Z),4-alfa,16-beta)-4,9-epoxicevano-3,4,12,14,16,17,20-heptol-3-(2-metil-2-butenoato)
Scope note: Activador de los canales del sodio dependientes de voltaje.
Descriptor Portuguese: Veratrina
Descriptor French: Vératrine
Entry term(s): Cevadine
Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(2-methyl-2-butenoate), (3beta(Z),4alpha,16beta)-
Tree number(s): D03.132.920.256.815
D03.633.400.256.815
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D014702
Scope note: A voltage-gated sodium channel activator.
Annotation: do not confuse with VERATRIDINE
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Sodium Channel Agonists
Registry Number: ERQ7M6C50B
CAS Type 1 Name: Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(2-methyl-2-butenoate), (3beta(Z),4alpha,16beta)-
History Note: 1973 (1963)
DeCS ID: 21077
Unique ID: D014702
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1973/01/01
Date of Entry: 1999/01/01
Revision Date: 2019/04/29
Veratrine - Preferred
Concept UI M0022612
Scope note A voltage-gated sodium channel activator.
Preferred term Veratrine
Entry term(s) Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(2-methyl-2-butenoate), (3beta(Z),4alpha,16beta)-
Cevadine - Narrower
Concept UI M000638572
Preferred term Cevadine



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey